Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Gout and Crystalline Arthritis

Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront

Daniel J. Wallace, MD, FACP, FACR  |  July 1, 2014

Researchers Scholosstein et al were first to connection HLA antigens to the inflammatory disease, not Brewerton et al as reported [The Rheumatologist, May 2014]

Aggregated Neutrophils Limit Inflammation

Lara C. Pullen, PhD  |  June 30, 2014

A new study suggests understanding this antiinflammatory pathway may lead to new immunomodulatory therapy for resolving inflammation

Clinical Applications of Dual-Energy Computed Tomography for Rheumatology

Nicola Dalbeth, MBChB, MD, FRACP  |  June 1, 2014

Advanced imaging technique allows physicians to detect deposition of monosodium urate crystals not apparent in physical exams and better diagnose gout

Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care

Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments

Staff  |  April 2, 2014

Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis

Research Reveals Clues Into Inflammatory Process of Crystal Arthropathies Note Experts at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein  |  March 1, 2014

New studies clarify the roles of monosodium urate crystals in gout, calcium pyrophosphate crystals in osteoarthritis, and identify more effective potential therapies for patients

Do Women Receive Worse Gout Treatment Than Men?

Richard Quinn  |  February 5, 2014

Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease.  (posted Feb. 5)

Letters: A Word of Caution on Colchicine Study

Gurjit S. Kaeley, MRCP  |  February 1, 2014

A rheumatologist warns against generalizing findings of the study reported in “Colchine Effective for Acute Pericarditis” [published online October 31, 2013] to all patients with rheumatic diseases

Colchicine Effective for Acute Pericarditis

Lara C. Pullen, PhD  |  October 25, 2013

Patients with acute pericarditis who are treated with colchicine in combination with a traditional antiinflammatory therapy experience a significantly reduced rate of incessant or recurrent pericarditis.  (posted Oct. 31)

  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 21
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences